Text resize: A A A

milestones

1991 | 1993 | 1994 | 1997 | 1999

The agreement with Dr. Reddy's Research Foundation is another very important step in Novo Nordisk's continued efforts to widen the scope of its research and to gain access to compounds which may prove useful in the treatment of diabetes and its complications.

Dr. Bruce Carter was Exec VP, Healthcare Discovery & Development at Novo Nordisk in 1997. Currently a member of the Board of directors at Dr. Reddy’s

Licenses anti-diabetic molecule, DRF 2593 (Balaglitazone), to Novo Nordisk. Becomes the first Indian pharmaceutical company to out-license an original molecule

Dr. Reddy’s Research Foundation (DRF) discovers one of the most potent glitazones [DRF 2593 (Balaglitazone)] and on March 1, 1997 licenses it to Novo Nordisk A/s of Denmark, the world leader in the diabetes.
Dr. Reddy’s becomes the first Indian pharmaceutical company to out-license an original molecule, a momentous occasion in the history of
Dr. Reddy’s and the Indian pharmaceutical industry.

Balaglitazone belongs to thiazolidinedione class of insulin sensitizers, later elucidated to be a partial PPAR agonist. The US Patents and Trademarks Office grant the first patent to DRF in December 1997 for the discovery of Troglitazone Polymorphs, a molecule with anti-diabetic properties.

Prime Minister I. K. Gujral presents the FICCI Award (1996-1997) to Chairman Dr. K. Anji Reddy in November 1997, in recognition of DRF's initiative in Research in Science and Technology.

Click to read related memories

First ANDA filed with the United States Food and Drug Administration for Ranitidine

Dr. Reddy’s files its ANDA with the United States Food and Drug Administration for Ranitidine. Ranitidine creates ripples not only in India but also in the global pharmaceutical circles.

Reddy Biomed Ltd is inaugurated in Moscow on March 26, 1997 by the then Prime Minister of India Shri H. D. Deve Gowda. Dr. Reddy’s starts a Joint Venture in Brazil in September 1997. Reddy Pharmed starts as a Joint Venture in Tashkent, Uzbekistan in October 1997.

Dr. Reddy’s Foundation, the CSR arm of Dr. Reddy’s which was inaugurated in 1996, initiates the Child and Police (CAP) Project in 1997 in association with the Andhra Pradesh State Police, creating a public-private partnership aimed at providing children access to quality education.

Click to read related memories

1997

Ranitidine- The company\'s first ANDA filed with USFDA .